Registered Number:11069157 |
For the year ended 31 March 2024
England and Wales
Unaudited Financial Statements
For the year ended 31 March 2024
Brampton Medical Ltd
Contents Page
1
Statement of Financial Position
2 to 5
Notes to the Financial Statements
Brampton Medical Ltd
Statement of Financial Position
2023
2024
Property, plant and equipment |
494,126
465,758
2
494,126
465,758
2,000
2,000
3
Trade and other receivables |
30,036
23,633
4
21,425
Cash and cash equivalents |
85,546
111,179
53,461
Trade and other payables: amounts falling due within one year |
(311,687)
(322,774)
5
(258,226)
(211,595)
Net current liabilities
Total assets less current liabilities |
282,531
207,532
Trade and other payables: amounts falling due after more than |
one year |
(36,337)
(60,977)
6
(25,796)
(19,806)
Provisions for liabilities |
195,758
Net assets
151,389
104
104
32,480
32,480
163,154
118,785
20
20
195,758
151,389
Shareholders' funds
For the year ended 31 March 2024 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies. |
The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006 |
The directors acknowledge their responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each |
financial year and of its profit or loss for each financial year in accordance with the requirements of Section 394 and 395 and |
which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as |
applicable to the company. |
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. |
1 of 5
For the year ended 31 March 2024
Brampton Medical Ltd
Statement of Financial Position Continued
Ms Elizabeth Anne Eleanor Gillow Director |
Mr John Timothy Joseph Gillow Director |
These financial statements were approved and authorised for issue by the Board on 25 September 2024 and were signed by: |
The notes form part of these financial statements |
2 of 5
For the year ended 31 March 2024
Brampton Medical Ltd
Notes to the Financial Statements
Statutory Information
Brampton Medical Ltd is a private limited company, limited by shares, domiciled in England and Wales, registration number |
11069157. |
36 Hanover Street
Newcastle Under Lyme
Staffordshire
ST5 1AU
The presentation currency is £ sterling. |
Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A of Financial Reporting |
Standard 102 ''The Financial Reporting Standard applicable in the UK and Republic of Ireland'' and the Companies Act 2006. |
The financial statements have been prepared under the historical costs convention as modified by the revaluation of certain |
assets. |
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax or other similar sales taxes. |
Property, plant and equipment
Property, plant and equipment, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis: There has been a change in accounting estimate, plant and machinery is now depreciated on a 20% reducing balance basis, previously a 10% straight line basis. |
Land and Buildings
Plant and Machinery
Computer Equipment
Motor Vehicles
Furniture and Fittings
Inventories
Inventories are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items. |
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date. |
Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme for the benefit of its directors/and employees. Contributions payable are charged to the profit and loss account in the period in which they are payable. |
3 of 5
For the year ended 31 March 2024
Brampton Medical Ltd
Notes to the Financial Statements Continued
2. Property, plant and equipment |
Motor Vehicles
557,551
8,682
50,011
29,072
78,769
391,017
57,740
381
-
-
57,359
-
391,017
29,072
50,011
9,063
615,291
136,128
Provision for depreciation and impairment |
91,793
4,433
43,719
12,719
30,922
-
Charge for year
29,372
1,529
2,713
4,088
21,042
-
121,165
5,962
46,432
16,807
51,964
-
391,017
84,164
12,265
3,579
3,101
494,126
391,017
47,847
16,353
6,292
4,249
465,758
2023
2024
2,000
2,000
4. Trade and other receivables |
2023
2024
11,810
10,880
11,823
19,156
30,036
23,633
5. Trade and other payables: amounts falling due within one year |
2023
2024
5,363
5,231
2,726
500
Taxation and social security |
6,155
18,127
308,530
287,829
322,774
311,687
4 of 5
For the year ended 31 March 2024
Brampton Medical Ltd
Notes to the Financial Statements Continued
6. Trade and other payables: amounts falling due after more than one year |
2023
2024
30,977
36,337
30,000
-
60,977
36,337
7. Related party transactions |
Included within other creditors is the directors loan account balance of £305,017 (2023 £284,353). This loan is interest free |
with no fixed date of repayment. |
8. Average number of persons employed |
During the year the average number of employees was 6 (2023 : 5)
5 of 5